INTERNATIONAL BIOTECHNOLOGY TRUST PLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 3.7%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q2 2023$6,890,950
-80.8%
67,000
-78.7%
2.10%
-81.0%
Q4 2022$35,828,179
+27.2%
314,973
-30.8%
11.06%
+22.5%
Q3 2022$28,158,000
-90.2%
454,973
+1885.5%
9.03%
+201.6%
Q2 2022$286,973,000
+3751.5%
22,915
-87.5%
2.99%
+78.2%
Q1 2022$7,451,000
-30.8%
183,473
+83.7%
1.68%
-29.9%
Q4 2021$10,762,000
-58.7%
99,873
-58.0%
2.40%
-61.8%
Q3 2021$26,042,000
+16.9%
237,8730.0%6.28%
+6.8%
Q2 2021$22,274,000
+558.6%
237,873
+85.8%
5.88%
+370.9%
Q1 2019$3,382,000
+219.4%
128,000
+85.5%
1.25%
+90.1%
Q4 2018$1,059,000
+2.2%
69,0000.0%0.66%
+33.5%
Q3 2018$1,036,000
-9.3%
69,0000.0%0.49%
+12.1%
Q2 2018$1,142,000
+16.6%
69,0000.0%0.44%
+14.9%
Q1 2018$979,000
-2.8%
69,0000.0%0.38%
+7.6%
Q4 2017$1,007,000
+15.0%
69,0000.0%0.36%
+4.1%
Q3 2017$876,000
-56.3%
69,000
-59.2%
0.34%
-55.2%
Q2 2017$2,004,000
+59.7%
169,000
+98.8%
0.76%
+58.8%
Q1 2017$1,255,000
-8.7%
85,0000.0%0.48%
-22.5%
Q4 2016$1,374,00085,0000.62%
Other shareholders
HORIZON PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,609,894$109,460,0003.84%
Avoro Capital Advisors LLC 5,593,683$92,631,0003.57%
Broadfin Capital, LLC 1,339,575$22,183,0003.49%
SCOPIA CAPITAL MANAGEMENT LP 11,912,290$197,268,0003.45%
JW Asset Management, LLC 270,775$4,484,0002.86%
Rhenman & Partners Asset Management AB 1,632,212$27,029,0002.77%
Paulson & Co. 7,670,700$127,027,0002.60%
Redwood Investments, LLC 1,315,149$21,779,0001.50%
KOPP INVESTMENT ADVISORS LLC 93,220$1,544,0001.45%
1492 Capital Management LLC 72,951$1,208,0000.86%
View complete list of HORIZON PHARMA PLC shareholders